L-Citrulline

L-Citrulline

SCHEMBL6930182

NC(=O)NCCCC(N)C(=O)O.NC(CS)C(=O)O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.55
SLC7A11 Q9UPY5 1/20 0.55
OTC P00480 1/20 0.51
DDAH1 O94760 3/20 0.48
NOS2 P35228 4/20 0.47
CYP2C19 P33261 2/20 0.47
CYP1A2 P05177 2/20 0.47
TSHR P16473 2/20 0.47
GLA P06280 1/20 0.47
NFKB1 P19838 1/20 0.47
APEX1 P27695 1/20 0.47
GSR P00390 1/20 0.44
KMT2A Q03164 2/20 0.41
ALOX15 P16050 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
NOS3 P29474 3/20 0.41
NOS1 P29475 3/20 0.41
MEN1 O00255 1/20 0.41
ARG2 P78540 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Citrulline SCHEMBL6930186 1.00 PTGS1 (0.55) PTGS1SLC7A11OTCDDAH1NOS2
Arginine SCHEMBL28106594 0.92 PTGS1 (0.47) PTGS1SLC7A11OTCDDAH1NOS2
L-Citrulline SCHEMBL4542892 0.91 OTC (0.59) OTCDDAH1NOS2CYP2C19CYP1A2
L-Citrulline SCHEMBL22426116 0.91 OTC (0.59) OTCDDAH1NOS2CYP2C19CYP1A2
L-Citrulline SCHEMBL15909605 0.91 OTC (0.59) OTCDDAH1NOS2CYP2C19CYP1A2
L-Citrulline SCHEMBL20587 0.91 OTC (0.59) OTCDDAH1NOS2CYP2C19CYP1A2
L-Citrulline SCHEMBL15909604 0.91 OTC (0.59) OTCDDAH1NOS2CYP2C19CYP1A2
L-Citrulline SCHEMBL215403 0.91 OTC (0.59) OTCDDAH1NOS2CYP2C19CYP1A2
L-Citrulline SCHEMBL437142 0.91 OTC (0.59) OTCDDAH1NOS2CYP2C19CYP1A2
L-Citrulline SCHEMBL9070200 0.91 OTC (0.59) OTCDDAH1NOS2CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104583213-B Substituted pyridine azoles and pyrimidine -5- (6H) -one compound 达特神经科学(开曼)有限公司 2018-10-26 CN disclosed
CN-104583217-B Substituted thiophene-fused and furan-fused oxazolopyrimidine-5- (6H) -one compounds 达特神经科学(开曼)有限公司 2017-11-17 CN disclosed
EP-0831703-A4 METHOD OF SOLUBILIZING AND ENCAPSULATING ITRACONAZOLE EMISPHERE TECH INC (US) 2003-05-21 EP disclosed
US-20030042638-A1 Method of solubilizing and encapsulating itraconazole KANTOR MARTIN L (US) 2003-03-06 US disclosed
US-6461545-B1 Method of solubilizing and encapsulating itraconazole EMISPHERE TECHNOLOGIES, INC. 2002-10-08 US disclosed
US-6100285-A SOLUTION OF ITRACONAZOLE DISSOLVED IN VOLATILE ORGANIC ACID SOLVENT; BIOAVAILABILITY EMISPHERE TECHNOLOGIES, INC. (US) 2000-08-08 US disclosed
US-5750147-A FUNGICIDES FOR ORAL ADMINISTRATION EMISPHERE TECHNOLOGIES, INC. (US) 1998-05-12 US disclosed
EP-0831703-A1 METHOD OF SOLUBILIZING AND ENCAPSULATING ITRACONAZOLE Emisphere Technologies, Inc. (US) 1998-04-01 EP disclosed
WO-1996039835-A1 METHOD OF SOLUBILIZING AND ENCAPSULATING ITRACONAZOLE EMISPHERE TECHNOLOGIES, INC. (US) 1996-12-19 WO disclosed